CEPLENE

This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Poland, Romania

Active ingredients

The drug CEPLENE contains one active pharmaceutical ingredient (API):

1 Histamine
UNII 3POA0Q644U - HISTAMINE DIHYDROCHLORIDE

Histamine/IL-2 is an immunotherapy which aims to induce immune-mediated destruction of residual myeloid leukaemic cells and thereby to prevent relapse of leukaemia. The role of histamine is to protect lymphocytes, in particular NK cells and T cells, which are responsible for the immune-mediated destruction of residual leukaemic cells.

Read about Histamine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CEPLENE Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AX14 Histamine dihydrochloride L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1382262
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1034469
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100127424
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W53539001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.